Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.89
+0.30 (3.95%)
At close: Mar 10, 2026, 4:00 PM EDT
7.86
-0.03 (-0.38%)
After-hours: Mar 10, 2026, 6:38 PM EDT

Fennec Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
269174303253114194
Market Cap Growth
45.50%-42.63%19.83%121.09%-40.91%50.03%
Enterprise Value
266.9166.67320.9254.1998.35163.38
Last Close Price
7.896.3211.229.604.407.45
PE Ratio
---18.70-10.67-6.57-9.80
Forward PE
15.47-90.85--8.87
PS Ratio
6.953.6614.27164.86-1139.54
PB Ratio
--29.63-26.09-98.517.266.66
P/TBV Ratio
-48.56-29.38-25.65-98.197.266.08
P/FCF Ratio
-6.45-17.69-14.01-8.05-12.42
P/OCF Ratio
-6.45-17.69-14.01-8.05-12.42
EV/Sales Ratio
6.883.5115.10165.60-961.05
EV/EBITDA Ratio
-49.49-25.13-11.25-5.71-9.13
EV/EBIT Ratio
-64.90-25.13-11.25-5.71-9.13
EV/FCF Ratio
-6.18-18.72-14.08-6.92-10.48
Debt / Equity Ratio
-4.31-3.29-2.66-9.690.320
Debt / EBITDA Ratio
-23.625.74-2.42-1.10-0.29-
Debt / FCF Ratio
-2.460.72-1.81-1.38-0.35-
Net Debt / Equity Ratio
0.521.24-1.52-0.44-1.02-1.04
Net Debt / EBITDA Ratio
2.79-2.17-1.38-0.050.941.70
Net Debt / FCF Ratio
0.29-0.27-1.03-0.061.131.95
Asset Turnover
0.821.320.790.0600.01
Inventory Turnover
1.511.980.920.30--
Quick Ratio
4.215.712.925.4912.7612.93
Current Ratio
4.696.383.565.8013.5413.39
Return on Equity (ROE)
54.92%-3.36%226.13%-359.22%-77.36%-88.46%
Return on Assets (ROA)
-1.98%-29.62%-47.47%-91.54%-63.99%-78.51%
Return on Invested Capital (ROIC)
-6.36%-120.11%-552.98%2532.40%2134.20%1173.17%
Return on Capital Employed (ROCE)
-2.41%8.96%-61.34%-104.85%-69.13%-87.36%
Earnings Yield
-2.58%0.00%-5.35%-9.38%-15.23%-10.20%
FCF Yield
-15.51%-5.65%-7.14%-12.43%-8.05%
Buyback Yield / Dilution
-1.07%-0.75%-0.57%-0.37%-0.03%-16.74%
Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q